Author:
Escobar-Cervantes Carlos,Villa Guillermo,Campos-Tapias Ignasi,Sorio-Vilela Francesc,Lozano Javier,Kahangire Doreen A.,Fernandez-Delgado Miriam,Sicras-Navarro Aram,Sicras-Mainar Antoni
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference26 articles.
1. Halcox JP, Banegas JR, Roy C, et al. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. BMC Cardiovasc Disord. 2017;17(1):160.
2. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.
3. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88.
4. Fundación Española del Corazón. Mortalidad cardiovascular en España en 2018. https://fundaciondelcorazon.com/corazon-facil/recursos-didacticos/infografias.html?download=63:la-mortalidad-cardiovascular-en-2018. Accessed 20 Feb 2022.
5. Roth GA, Fihn SD, Mokdad AH, Aekplakorn W, Hasegawa T, Lim SS. High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries. Bull World Health Organ. 2011;89(2):92–101.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献